Healthcare -
Biotechnology - NASDAQ - FR
$ 2.1264
0.302 %
$ 178 M
Market Cap
-4.83
P/E
IPHA - OPERATING EXPENSES
Operating Expenses IPHA - Innate Pharma S.A.
64.6 M
LAST VALUE
3.79%
2 YEAR CAGR
-2.88%
5 YEAR CAGR
23.76%
10 YEAR CAGR